Vaccine development against Neisseria meningitidis.
Meningococcal disease is communicable by close contact or droplet aerosols. Striking features are high case fatality rates and peak incidences of invasive disease in infants, toddlers and adolescents. Vaccine development is hampered by bacterial immune evasion strategies including molecular mimicry.As for Haemophilus influenzae and Streptococcus pneumoniae, no vaccine has therefore been developed that targets all serogroups of Neisseria meningitidis. Polysaccharide vaccines available both in protein conjugated and non-conjugated form, have been introduced against capsular serogroups A, C,W-135 and Y, but are ineffective against serogroup B meningococci, which cause a significant burden of disease in many parts of the world. Detoxified outer membrane vesicles are used since decades to elicit protection against epidemic serogroup B disease. Genome mining and biochemical approaches have provided astounding progress recently in the identification of immunogenic, yet reasonably conserved outer membrane proteins. As subcapsular proteins nevertheless are unlikely to immunize against all serogroup B variants, thorough investigation by surrogate assays and molecular epidemiology approaches are needed prior to introduction and post-licensure of protein vaccines. Research currently addresses the analysis of life vaccines, meningococcus B polysaccharide modifications and mimotopes, as well as the use of N. lactamica outer membrane vesicles.
University of Würzburg, Institute for Hygiene and Microbiology, Reference Laboratory for Meningococci, Germany. uvogel@hygiene.uni-wuerzburg.de
Ulrich
U
Vogel
Heike
H
Claus
D000818:Animals; D015195:Drug Design; D006801:Humans; D008589:Meningococcal Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000235:genetics / Q000276:immunology*; D009345:Neisseria meningitidis / Q000235:genetics / Q000276:immunology*
D022401:Meningococcal Vaccines
Vaccine. 2008 Aug 5;26(33):4244-50
18582996
Infect Immun. 2004 Apr;72(4):1914-9
15039310
Nature. 2000 Mar 30;404(6777):502-6
10761919
Hum Vaccin. 2008 Jan-Feb;4(1):23-30
17921703
N Engl J Med. 2000 Jan 20;342(3):219-20
10651563
J Clin Microbiol. 2009 Nov;47(11):3577-85
19759227
Arch Pediatr Adolesc Med. 2005 Oct;159(10):907-13
16203934
Infect Immun. 2004 Oct;72(10):5955-62
15385499
J Clin Microbiol. 1988 Oct;26(10):1988-92
3141457
Microbiology (Reading). 2003 Jul;149(Pt 7):1849-1858
12855736
Lancet. 1999 Aug 21;354(9179):615-6
10466659
Infect Immun. 2001 Oct;69(10):5981-90
11553534
J Immunol. 1998 May 15;160(10):5028-36
9590252
Clin Infect Dis. 2007 Nov 15;45(10):1327-34
17968829
Microb Pathog. 1989 Jun;6(6):455-8
2505013
Clin Infect Dis. 2007 Mar 1;44(5):657-63
17278055
NIPH Ann. 1991 Dec;14(2):195-207; discussion 208-10
1812432
J Infect Dis. 2001 Jan 1;183(1):160-3
11078484
Vaccine. 2007 Dec 5;25(50):8420-31
17996338
J Biol Chem. 2004 Oct 8;279(41):42765-73
15294916
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4927-31
3088568
Infect Immun. 2009 May;77(5):2084-93
19289516
Mol Microbiol. 2009 Feb;71(4):960-71
19170877
Mol Microbiol. 2004 Jan;51(1):227-39
14651624
J Infect Dis. 2006 Dec 15;194(12):1745-52
17109348
Science. 2000 Mar 10;287(5459):1816-20
10710308
Lancet. 1992 Oct 31;340(8827):1074-8
1357461
J Infect Dis. 1997 Feb;175(2):364-72
9203657
J Biol Chem. 1974 Apr 10;249(7):2275-81
4206552
Microbiology (Reading). 2002 Jun;148(Pt 6):1813-1819
12055301
Mol Gen Genet. 1997 Dec;257(1):28-34
9439566
J Clin Microbiol. 2004 Jul;42(7):2898-901
15243035
Mol Microbiol. 1992 Feb;6(4):489-95
1560777
Genomics. 2008 Jan;91(1):78-87
18031983
Clin Infect Dis. 2005 Mar 1;40(5):e38-42
15714405
J Infect Dis. 1978 Feb;137(2):112-21
415097
Vaccine. 2009 May 26;27(25-26):3417-21
19200847
J Immunol. 2009 May 15;182(10):6610-7
19414816
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9542-7
12883001
Vaccine. 2005 Mar 18;23(17-18):2191-6
15755593
Hum Vaccin. 2008 Mar-Apr;4(2):158-61
18388494
J Immunol. 2006 Jul 1;177(1):501-10
16785547
Infect Immun. 2004 Jul;72(7):4217-23
15213166
Infect Immun. 2002 Jul;70(7):3707-13
12065513
PLoS Genet. 2007 Feb 16;3(2):e23
17305430
Infect Immun. 2007 Nov;75(11):5434-42
17664268
Lancet. 1991 Nov 2;338(8775):1093-6
1682541
J Biol Chem. 2009 Mar 27;284(13):8738-46
19103601
Proteomics. 2008 May;8(10):2115-25
18491322
Dev Biol (Basel). 2000;103:151-60
11214233
Vaccine. 2009 Jan 1;27(1):161-8
18834910
J Immunol. 2007 Apr 1;178(7):4417-23
17371999
J Infect Dis. 2005 Apr 15;191(8):1263-71
15776372
Int J Epidemiol. 2000 Feb;29(1):180-8
10750621
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15082-7
18815379
Hum Vaccin. 2005 Jul-Aug;1(4):131-9
17012872
Can J Biochem. 1976 Jan;54(1):1-8
814976
J Clin Invest. 2009 Sep;119(9):2515-25
19729849
J Infect Dis. 1977 Aug;136 Suppl:S78-83
408435
Infect Immun. 2004 Apr;72(4):2088-100
15039331
FEMS Microbiol Rev. 2006 Mar;30(2):292-319
16472308
Vaccine. 2009 Jun 24;27 Suppl 2:B42-50
19481315
Euro Surveill. 2004 Jul;9(7):11-5
15318008
Science. 2000 Mar 10;287(5459):1809-15
10710307
J Infect Dis. 2009 Aug 1;200(3):379-89
19534597
Emerg Infect Dis. 2006 Nov;12(11):1689-95
17283618
Vaccine. 2007 Sep 3;25 Suppl 1:A101-7
17532101
J Infect Dis. 2007 Apr 1;195(7):1071-7
17330799
J Exp Med. 1987 Apr 1;165(4):1207-11
2435835
J Med Microbiol. 2002 Sep;51(9):717-722
12358061
Pediatr Infect Dis J. 2005 Feb;24(2):128-31
15702040
FEMS Microbiol Rev. 2007 Jan;31(1):52-63
17233635
Emerg Infect Dis. 2004 Apr;10(4):674-8
15200858
Nat Rev Microbiol. 2008 Jun;6(6):431-40
18461076
Trop Med Int Health. 2003 Dec;8(12):1118-23
14641847
Microbiology (Reading). 2009 Dec;155(Pt 12):4155-4169
19729409
Infect Immun. 2001 May;69(5):3335-42
11292756
BMC Microbiol. 2008 Apr 22;8:66
18430216
FEMS Microbiol Rev. 2007 Jan;31(1):3-14
17233633
Expert Rev Vaccines. 2006 Dec;5(6):851-7
17184222
Vaccine. 2008 Aug 18;26(35):4434-45
18617296
Clin Vaccine Immunol. 2010 Jan;17(1):154-9
19906895
Vaccine. 2009 Apr 14;27(17):2320-5
19428846
BMJ. 2003 Feb 15;326(7385):365-6
12586669
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3473-8
18305155
Am J Epidemiol. 2007 Oct 1;166(7):817-23
17615088
J Exp Med. 1974 Jul 1;140(1):87-104
4134571
Euro Surveill. 2006 Jul;11(7):178-81
16966800
Clin Infect Dis. 2006 Dec 1;43(11):1387-94
17083009
Vaccine. 2005 Mar 18;23(17-18):2202-5
15755595
J Infect Dis. 2005 Aug 15;192(4):580-90
16028126
Infect Immun. 2008 Nov;76(11):5412-20
18794285
J Clin Microbiol. 2007 Jan;45(1):159-67
17093016
Vaccine. 2004 Mar 12;22(9-10):1087-96
15003635
Vaccine. 2009 May 11;27(21):2794-803
19428890
JAMA. 2008 Jan 9;299(2):173-84
18182599
Nature. 2009 Apr 16;458(7240):890-3
19225461
Vaccine. 2007 Sep 3;25 Suppl 1:A97-100
17521780
J Infect Dis. 2008 Mar 1;197(5):737-43
18271745
J Biol Chem. 2009 Apr 3;284(14):9022-6
19196709
Infect Immun. 2002 Jul;70(7):3621-6
12065503
Yonsei Med J. 2004 Aug 31;45(4):755-8
15344223
J Exp Med. 2002 Jun 3;195(11):1445-54
12045242
Clin Vaccine Immunol. 2010 Jan;17(1):98-107
19923573
Lancet. 2004 Jul 24-30;364(9431):365-7
15276396
J Biol Chem. 1975 Mar 10;250(5):1926-32
163259
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10834-9
16825336
Microbiology (Reading). 2009 Sep;155(Pt 9):2873-2883
19574307
Infect Immun. 2004 Jan;72(1):345-51
14688114
Vaccine. 2005 Mar 18;23(17-18):2206-9
15755596
Mol Microbiol. 2000 Jun;36(5):1049-58
10844690
Lancet. 2002 May 25;359(9320):1829-31
12044380
Infect Immun. 2001 Mar;69(3):1561-7
11179327
J Biol Chem. 1998 Oct 30;273(44):28557-9
9786844
Hum Vaccin. 2006 Mar-Apr;2(2):68-73
17012888
Clin Vaccine Immunol. 2009 Aug;16(8):1113-20
19553555